spacer
spacer

PDBsum entry 2cgo

Go to PDB code: 
protein ligands metals links
Oxidoreductase PDB id
2cgo

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
339 a.a. *
Ligands
FUM
SO4 ×4
Metals
_FE
Waters ×121
* Residue conservation analysis
PDB id:
2cgo
Name: Oxidoreductase
Title: Factor inhibiting hif-1 alpha with fumarate
Structure: Hypoxia-inducible factor 1 alpha inhibitor. Chain: a. Synonym: factor inhibiting hif1, hypoxia-inducible factor asparagine hydroxylase, fih-1. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 469008.
Resolution:
2.30Å     R-factor:   0.192     R-free:   0.237
Authors: M.A.Mcdonough,I.J.Clifton,C.J.Schofield
Key ref:
K.S.Hewitson et al. (2007). Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. J Biol Chem, 282, 3293-3301. PubMed id: 17135241 DOI: 10.1074/jbc.M608337200
Date:
09-Mar-06     Release date:   13-Dec-06    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Q9NWT6  (HIF1N_HUMAN) -  Hypoxia-inducible factor 1-alpha inhibitor from Homo sapiens
Seq:
Struc:
349 a.a.
339 a.a.
Key:    Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class 1: E.C.1.14.11.30  - hypoxia-inducible factor-asparagine dioxygenase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-asparaginyl-[hypoxia-inducible factor alpha subunit] + 2-oxoglutarate + O2 = (3S)-3-hydroxy-L-asparaginyl-[hypoxia-inducible factor alpha subunit] + succinate + CO2
L-asparaginyl-[hypoxia-inducible factor alpha subunit]
+ 2-oxoglutarate
+ O2
= (3S)-3-hydroxy-L-asparaginyl-[hypoxia-inducible factor alpha subunit]
+ succinate
+
CO2
Bound ligand (Het Group name = FUM)
corresponds exactly
      Cofactor: Fe(2+); L-ascorbate
Fe(2+)
L-ascorbate
   Enzyme class 2: E.C.1.14.11.n4  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1074/jbc.M608337200 J Biol Chem 282:3293-3301 (2007)
PubMed id: 17135241  
 
 
Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.
K.S.Hewitson, B.M.Liénard, M.A.McDonough, I.J.Clifton, D.Butler, A.S.Soares, N.J.Oldham, L.A.McNeill, C.J.Schofield.
 
  ABSTRACT  
 
In humans both the levels and activity of the alpha-subunit of the hypoxia-inducible transcription factor (HIF-alpha) are regulated by its post-translation hydroxylation as catalyzed by iron- and 2-oxoglutarate (2OG)-dependent prolyl and asparaginyl hydroxylases (PHD1-3 and factor-inhibiting HIF (FIH), respectively). One consequence of hypoxia is the accumulation of tricarboxylic acid cycle intermediates (TCAIs). In vitro assays were used to assess non-2OG TCAIs as inhibitors of purified PHD2 and FIH. Under the assay conditions, no significant FIH inhibition was observed by the TCAIs or pyruvate, but fumarate, succinate, and isocitrate inhibited PHD2. Mass spectrometric analyses under nondenaturing conditions were used to investigate the binding of TCAIs to PHD2 and supported the solution studies. X-ray crystal structures of FIH in complex with Fe(II) and fumarate or succinate revealed similar binding modes for each in the 2OG co-substrate binding site. The in vitro results suggest that the cellular inhibition of PHD2, but probably not FIH, by fumarate and succinate may play a role in the Warburg effect providing that appropriate relative concentrations of the components are achieved under physiological conditions.
 
  Selected figure(s)  
 
Figure 1.
FIGURE 1. The reactions catalyzed by the HIF hydroxylases (PHDs and FIH).
Figure 4.
FIGURE 4. Inhibition of t-PHD2 by the TCAIs (at 1 mM final concentration). No inc refers to the assay without a preincubation step; 1hrinc refers to a 1-h preincubation of t-PHD2 with iron, buffer, and compound (where applicable), and 1hrinc + asc refers to a 1-h preincubation of t-PHD2 with iron, buffer, and ascorbate.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2007, 282, 3293-3301) copyright 2007.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21303451 A.E.Hansen, A.T.Kristensen, I.Law, J.T.Jørgensen, and S.A.Engelholm (2011).
Hypoxia-inducible factors--regulation, role and comparative aspects in tumourigenesis.
  Vet Comp Oncol, 9, 16-37.  
21301796 C.Frezza, P.J.Pollard, and E.Gottlieb (2011).
Inborn and acquired metabolic defects in cancer.
  J Mol Med, 89, 213-220.  
21460794 R.Chowdhury, K.K.Yeoh, Y.M.Tian, L.Hillringhaus, E.A.Bagg, N.R.Rose, I.K.Leung, X.S.Li, E.C.Woon, M.Yang, M.A.McDonough, O.N.King, I.J.Clifton, R.J.Klose, T.D.Claridge, P.J.Ratcliffe, C.J.Schofield, and A.Kawamura (2011).
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.
  EMBO Rep, 12, 463-469.
PDB codes: 2ybk 2ybp 2ybs 2yc0 2yde
20574807 G.Czibik (2010).
Complex role of the HIF system in cardiovascular biology.
  J Mol Med, 88, 1101-1111.  
19942427 G.L.Semenza (2010).
HIF-1: upstream and downstream of cancer metabolism.
  Curr Opin Genet Dev, 20, 51-56.  
20396966 H.Moon, S.Han, H.Park, and J.Choe (2010).
Crystal structures of human FIH-1 in complex with quinol family inhibitors.
  Mol Cells, 29, 471-474.
PDB codes: 3kcx 3kcy
20415579 J.M.Phang, W.Liu, and O.Zabirnyk (2010).
Proline metabolism and microenvironmental stress.
  Annu Rev Nutr, 30, 441-463.  
20660115 L.O'Flaherty, J.Adam, L.C.Heather, A.V.Zhdanov, Y.L.Chung, M.X.Miranda, J.Croft, S.Olpin, K.Clarke, C.W.Pugh, J.Griffiths, D.Papkovsky, H.Ashrafian, P.J.Ratcliffe, and P.J.Pollard (2010).
Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism.
  Hum Mol Genet, 19, 3844-3851.  
20094655 M.Sakurai, N.R.Rose, L.Schultz, A.M.Quinn, A.Jadhav, S.S.Ng, U.Oppermann, C.J.Schofield, and A.Simeonov (2010).
A miniaturized screen for inhibitors of Jumonji histone demethylases.
  Mol Biosyst, 6, 357-364.  
19754349 S.Nagel, N.P.Talbot, J.Mecinović, T.G.Smith, A.M.Buchan, and C.J.Schofield (2010).
Therapeutic manipulation of the HIF hydroxylases.
  Antioxid Redox Signal, 12, 481-501.  
20178464 T.Jokilehto, and P.M.Jaakkola (2010).
The role of HIF prolyl hydroxylases in tumour growth.
  J Cell Mol Med, 14, 758-770.  
19519624 D.Schubert, T.Soucek, and B.Blouw (2009).
The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide.
  Eur J Neurosci, 29, 1323-1334.  
19268693 E.Roudier, and A.Perrin (2009).
Considering the role of pyruvate in tumor cells during hypoxia.
  Biochim Biophys Acta, 1796, 55-62.  
19821261 R.Paddenberg, N.Howold, C.Hoger, H.Janssen, V.Grau, and W.Kummer (2009).
Organ preservation solutions attenuate accumulation and nuclear translocation of hypoxia-inducible factor-1alpha in the hepatoma cell line HepG2.
  Cell Biochem Funct, 27, 516-525.  
18617893 B.Bleijlevens, T.Shivarattan, E.Flashman, Y.Yang, P.J.Simpson, P.Koivisto, B.Sedgwick, C.J.Schofield, and S.J.Matthews (2008).
Dynamic states of the DNA repair enzyme AlkB regulate product release.
  EMBO Rep, 9, 872-877.  
19048166 B.M.Lienard, A.Conejo-García, I.Stolze, C.Loenarz, N.J.Oldham, P.J.Ratcliffe, and C.J.Schofield (2008).
Evaluation of aspirin metabolites as inhibitors of hypoxia-inducible factor hydroxylases.
  Chem Commun (Camb), (), 6393-6395.  
18259202 G.H.Fong, and K.Takeda (2008).
Role and regulation of prolyl hydroxylase domain proteins.
  Cell Death Differ, 15, 635-641.  
18202699 K.Lisy, and D.J.Peet (2008).
Turn me on: regulating HIF transcriptional activity.
  Cell Death Differ, 15, 642-649.  
18332118 T.Bishop, D.Gallagher, A.Pascual, C.A.Lygate, J.P.de Bono, L.G.Nicholls, P.Ortega-Saenz, H.Oster, B.Wijeyekoon, A.I.Sutherland, A.Grosfeld, J.Aragones, M.Schneider, K.van Geyte, D.Teixeira, A.Diez-Juan, J.Lopez-Barneo, K.M.Channon, P.H.Maxwell, C.W.Pugh, A.M.Davies, P.Carmeliet, and P.J.Ratcliffe (2008).
Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice.
  Mol Cell Biol, 28, 3386-3400.  
18541534 T.McFate, A.Mohyeldin, H.Lu, J.Thakar, J.Henriques, N.D.Halim, H.Wu, M.J.Schell, T.M.Tsang, O.Teahan, S.Zhou, J.A.Califano, N.H.Jeoung, R.A.Harris, and A.Verma (2008).
Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells.
  J Biol Chem, 283, 22700-22708.  
18498744 W.G.Kaelin, and P.J.Ratcliffe (2008).
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
  Mol Cell, 30, 393-402.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer